We also analyzed the correlation between the levels of IL-17 and clinical stages in 38 cases incipient MM patients, then we found that levels of IL-17 in the DS staging group A patients was lower than the patients in group B, instructing the correlation between renal damage and elevated levels of IL-17 in patients. This evidence concerns the gene IL17A and Miyoshi myopathy.